Hamza Suria - 04 Nov 2021 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
President, CEO, Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
04 Nov 2021
Net transactions value
-$689,831
Form type
4
Filing time
05 Nov 2021, 18:24:17 UTC
Previous filing
02 Nov 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Options Exercise $6,786 +6,059 +9% $1.12* 73,695 04 Nov 2021 Direct
transaction ANAB Common Stock Sale $212,065 -6,059 -8.2% $35.00 67,636 04 Nov 2021 Direct F1
transaction ANAB Common Stock Options Exercise $16,018 +14,302 +21% $1.12* 81,938 05 Nov 2021 Direct
transaction ANAB Common Stock Sale $500,570 -14,302 -17% $35.00 67,636 05 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Employee Stock Option (Right to Buy) Options Exercise $0 -6,059 -30% $0.000000 14,302 04 Nov 2021 Common Stock 6,059 $1.12 Direct F2, F3
transaction ANAB Employee Stock Option (Right to Buy) Options Exercise $0 -14,302 -100% $0.000000* 0 05 Nov 2021 Common Stock 14,302 $1.12 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2 The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021.
F3 In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.